RecruitingNot ApplicableNCT03710902

Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke

Sponsor

Jukka Putaala

Enrollment

405 participants

Start Date

Oct 17, 2018

Study Type

INTERVENTIONAL

Conditions

Atrial Fibrillation Hypertension Ischemic Stroke Transient Ischemic Attack Empowerment

Summary

The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.

Eligibility

Min Age: 40 Years

Inclusion Criteria4

Ischemic stroke or transient ischemic attack (ABCD2 score ≥3)
Age ≥40 years
Pre-existing or newly diagnosed hypertension
Informed consent from the patient or legal representative

Exclusion Criteria6

Known high-risk source of cardioembolism
Known indication for anticoagulation
Contraindication for anticoagulation
Pacemaker
Non-compliance to study interventions as judged by the investigator
Serious condition hampering the study conduct

Interventions

DIAGNOSTIC_TESTECG monitoring for 3 weeks

A 3-week continuous ECG monitoring to detect occult AF.

OTHERSelf-monitoring of BP and self-titration of antihypertensive medication

One-week monthly self-monitoring of BP and self-titration of antihypertensive medication according to a pre-specified protocol, assisted with a mobile device application.